MoneyWorks4Me

Hikal - Quaterly Results

01 Aug 2024 Evaluate
A minor change in the total revenue was seen in the June 2024 quarter. The total revenue for the quarter stood at Rs. 4068.00 millions against Rs. 3880.00 millions during year ago period.A slender decline of -24.64% was recorded to Rs. 52.00  millions from Rs. 69.00 millions in the corresponding previous quarter.Operating Profit saw a handsome growth to 586.00 millions from 512.00 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 4068.00 3880.00 4.85 4068.00 3880.00 4.85 17846.00 20230.30 -11.79
Other Income 5.00 9.00 -44.44 5.00 9.00 -44.44 24.50 54.10 -54.71
PBIDT 586.00 512.00 14.45 586.00 512.00 14.45 2693.90 2624.70 2.64
Interest 198.00 138.00 43.48 198.00 138.00 43.48 563.70 481.00 17.19
PBDT 388.00 374.00 3.74 388.00 374.00 3.74 2130.20 2143.70 -0.63
Depreciation 318.00 277.00 14.80 318.00 277.00 14.80 1176.10 1090.10 7.89
PBT 70.00 97.00 -27.84 70.00 97.00 -27.84 954.10 1053.60 -9.44
TAX 18.00 28.00 -35.71 18.00 28.00 -35.71 259.00 269.80 -4.00
Deferred Tax 3.00 1.00 200.00 3.00 1.00 200.00 -24.70 -35.00 -29.43
PAT 52.00 69.00 -24.64 52.00 69.00 -24.64 695.10 783.80 -11.32
Equity 247.00 246.60 0.16 247.00 246.60 0.16 246.60 246.60 0.00
PBIDTM(%) 14.41 13.20 9.16 14.41 13.20 9.16 15.10 12.97 16.35
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..